The Tata Memorial Hospital (TMH) is all set to start a 10-year long pan India clinical study in a month’s time to determine the efficacy of Aspirin in preventing the risk of cancer relapses.
The study titled “Add- Aspirin†is a joint initiative of TMH and the UK-based Medical Research Council involving 60 Indian investigators and 300 investigators from the UK. TMH recently received clinical trial approval from Ethics Committee of ICMR.
http://www.pharmabiz.com/NewsDetails.aspx?aid=100104&sid=1
Tata Memorial Hospital to begin 10-yr long pan India study of aspirin in preventing cancer relapses